Resveratrol enhanced chemosensitivity by reversing macrophage polarization in breast cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Resveratrol enhanced chemosensitivity by reversing macrophage polarization in breast cancer
Authors
Keywords
-
Journal
Clinical & Translational Oncology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-12-03
DOI
10.1007/s12094-021-02731-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial‑ mesenchymal transition via the AKT/GSK‑3β/Snail signaling pathway
- (2019) Li Yuan et al. Molecular Medicine Reports
- IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma
- (2018) Zi Yin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- IL-6 influences the polarization of macrophages and the formation and growth of colorectal tumor
- (2018) Lechuang Chen et al. Oncotarget
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tumor-associated macrophages: from basic research to clinical application
- (2017) Li Yang et al. Journal of Hematology & Oncology
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Tumor microenvironment-mediated chemoresistance in breast cancer
- (2016) Kobra velaei et al. BREAST
- Deletion of interleukin-6 in monocytes/macrophages suppresses the initiation of hepatocellular carcinoma in mice
- (2016) Lingxiang Kong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Resveratrol inhibits ovarian tumor growth in an in vivo mouse model
- (2015) Lijun Tan et al. CANCER
- Cancer prevention and therapy through the modulation of the tumor microenvironment
- (2015) Stephanie C. Casey et al. SEMINARS IN CANCER BIOLOGY
- Resveratrol and cancer: focus on in vivo evidence
- (2014) Lindsay G Carter et al. ENDOCRINE-RELATED CANCER
- Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages
- (2014) Soo Kyung Jeong et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Resveratrol Inhibits Breast Cancer Stem-Like Cells and Induces Autophagy via Suppressing Wnt/β-Catenin Signaling Pathway
- (2014) Yujie Fu et al. PLoS One
- Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin
- (2013) Tae Hyung Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
- (2013) Joao Tomé-Carneiro et al. CURRENT PHARMACEUTICAL DESIGN
- The role of tumor-associated macrophages in breast cancer progression
- (2013) ELIAS OBEID et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Emerging Glycolysis Targeting and Drug Discovery from Chinese Medicine in Cancer Therapy
- (2012) Zhiyu Wang et al. Evidence-based Complementary and Alternative Medicine
- Basal-like Breast Cancer Cells Induce Phenotypic and Genomic Changes in Macrophages
- (2012) Delisha A. Stewart et al. MOLECULAR CANCER RESEARCH
- Resveratrol: Biological and pharmaceutical properties as anticancer molecule
- (2010) Tze-chen Hsieh et al. BIOFACTORS
- Implications of Anthracycline-Resistant and Taxane-Resistant Metastatic Breast Cancer and New Therapeutic Options
- (2010) Edgardo Rivera Breast Journal
- Cellular signaling perturbation by natural products
- (2009) Fazlul H. Sarkar et al. CELLULAR SIGNALLING
- LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression
- (2009) Ja Eun Kim et al. EXPERIMENTAL AND MOLECULAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started